These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10516415

  • 1. Metformin and risk of cardiovascular disease.
    Turner RC, Holman RR.
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract] [Full Text] [Related]

  • 2. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C, Monami M, Marchionni N, Mannucci E.
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [Abstract] [Full Text] [Related]

  • 3. [Not Available].
    Steurer J.
    Praxis (Bern 1994); 2016 Sep; 105(20):1221-1222. PubMed ID: 27705192
    [No Abstract] [Full Text] [Related]

  • 4. Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.
    Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M.
    Cardiology; 1999 Sep; 91(3):195-202. PubMed ID: 10516414
    [Abstract] [Full Text] [Related]

  • 5. Intensive glucose lowering treatment in type 2 diabetes.
    Preiss D, Ray KK.
    BMJ; 2011 Jul 26; 343():d4243. PubMed ID: 21791496
    [No Abstract] [Full Text] [Related]

  • 6. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
    Sillars B, Davis WA, Hirsch IB, Davis TM.
    Diabetes Obes Metab; 2010 Sep 26; 12(9):757-65. PubMed ID: 20649627
    [Abstract] [Full Text] [Related]

  • 7. Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.
    Tayek JA.
    Diabetologia; 2006 Nov 26; 49(11):2807-8. PubMed ID: 16955252
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. All-cause mortality and cardiovascular effects associated with the DPP-IV inhibitor sitagliptin compared with metformin, a retrospective cohort study on the Danish population.
    Scheller NM, Mogensen UM, Andersson C, Vaag A, Torp-Pedersen C.
    Diabetes Obes Metab; 2014 Mar 26; 16(3):231-6. PubMed ID: 24020750
    [Abstract] [Full Text] [Related]

  • 11. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Trevisan R, Vedovato M, Cavalot F, Cignarelli M, Morano S, Ferrannini E, Pugliese G, Renal Insufficiency and Cardiovascular Events Study Group.
    J Am Geriatr Soc; 2013 Aug 26; 61(8):1253-61. PubMed ID: 23889588
    [Abstract] [Full Text] [Related]

  • 12. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb 26; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 13. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments.
    Gore MO, McGuire DK.
    Eur Heart J; 2011 Aug 26; 32(15):1832-4. PubMed ID: 21471136
    [No Abstract] [Full Text] [Related]

  • 14. [Life expectancy decreased by 1/3rd. Who to sink the vascular risk of type 2 diabetic patients?].
    MMW Fortschr Med; 2001 Dec 06; 143(49-50):56. PubMed ID: 11808457
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.
    Correia S, Carvalho C, Santos MS, Seiça R, Oliveira CR, Moreira PI.
    Mini Rev Med Chem; 2008 Nov 06; 8(13):1343-54. PubMed ID: 18991752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metformin.
    Bloomgarden ZT.
    Diabetes Care; 1995 Jul 06; 18(7):1078-80. PubMed ID: 7555549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.